The feasibility of team care for women seeking to plan a vaginal breech birth (OptiBreech 1): an observational implementation feasibility study in preparation for a pilot trial.
Breech presentation
Feasibility
Implementation
Intrapartum care
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
12 May 2023
12 May 2023
Historique:
received:
17
10
2022
accepted:
10
04
2023
medline:
13
5
2023
pubmed:
13
5
2023
entrez:
12
5
2023
Statut:
epublish
Résumé
OptiBreech Care is a care pathway for breech presentation at term, including where chosen, physiological breech birth attended by professionals with advanced training and/or proficiency. We aimed to assess the feasibility of implementing OptiBreech team care prior to proceeding with a planned pilot randomised controlled trial. Our design was an observational implementation feasibility assessment across England and Wales, January 2021-June 2022. Our objectives were to determine whether Trusts could provide attendants with advanced training (implementation feasibility), who deliver protocol-consistent care (fidelity), within existing resources (costs), while maintaining low neonatal admission rates (safety) and adequate recruitment rates (trial feasibility). Participants included women > 37 weeks pregnant with a breech-presenting foetus, requesting support for a vaginal breech birth following standard counselling, and staff involved in the study. No randomisation occurred in this first stage of feasibility work. Thirteen National Health Service sites were recruited. A total of 82 women planned births in the study. Sites with a breech specialist midwife recruited at double the rate of sites without (0.90/month, 95% CI 0.64-1.16 vs 0.40, 95% CI 0.12-0.68). Referrals into the study came from midwives (46%), obstetricians (34%) and women themselves (20%). Vaginal births were attended by staff with OptiBreech training at 87.5% (35/40, 95% CI 0.732-0.958) and by staff who met additional proficiency criteria at 67.5% (27/40, 95% CI 0.509-0.814). Fidelity criteria were more consistently met by staff who also met proficiency criteria. There were four neonatal admissions (4.9%, 4/82), including one serious adverse outcome (1.2%, 1/82). A prospective observational cohort of OptiBreech collaborative care, which could potentially support nested or cluster randomisation, appears feasible in sites willing to establish a dedicated clinic and strategically develop further proficient members of staff, with back-up plans for supporting rapidly progressing births. Randomisation procedures remain to be feasibility tested. It is funded by the NIHR (NIHR300582).
Sections du résumé
BACKGROUND
BACKGROUND
OptiBreech Care is a care pathway for breech presentation at term, including where chosen, physiological breech birth attended by professionals with advanced training and/or proficiency. We aimed to assess the feasibility of implementing OptiBreech team care prior to proceeding with a planned pilot randomised controlled trial.
METHODS
METHODS
Our design was an observational implementation feasibility assessment across England and Wales, January 2021-June 2022. Our objectives were to determine whether Trusts could provide attendants with advanced training (implementation feasibility), who deliver protocol-consistent care (fidelity), within existing resources (costs), while maintaining low neonatal admission rates (safety) and adequate recruitment rates (trial feasibility). Participants included women > 37 weeks pregnant with a breech-presenting foetus, requesting support for a vaginal breech birth following standard counselling, and staff involved in the study. No randomisation occurred in this first stage of feasibility work.
RESULTS
RESULTS
Thirteen National Health Service sites were recruited. A total of 82 women planned births in the study. Sites with a breech specialist midwife recruited at double the rate of sites without (0.90/month, 95% CI 0.64-1.16 vs 0.40, 95% CI 0.12-0.68). Referrals into the study came from midwives (46%), obstetricians (34%) and women themselves (20%). Vaginal births were attended by staff with OptiBreech training at 87.5% (35/40, 95% CI 0.732-0.958) and by staff who met additional proficiency criteria at 67.5% (27/40, 95% CI 0.509-0.814). Fidelity criteria were more consistently met by staff who also met proficiency criteria. There were four neonatal admissions (4.9%, 4/82), including one serious adverse outcome (1.2%, 1/82).
CONCLUSIONS
CONCLUSIONS
A prospective observational cohort of OptiBreech collaborative care, which could potentially support nested or cluster randomisation, appears feasible in sites willing to establish a dedicated clinic and strategically develop further proficient members of staff, with back-up plans for supporting rapidly progressing births. Randomisation procedures remain to be feasibility tested. It is funded by the NIHR (NIHR300582).
Identifiants
pubmed: 37173798
doi: 10.1186/s40814-023-01299-x
pii: 10.1186/s40814-023-01299-x
pmc: PMC10175899
doi:
Types de publication
Journal Article
Langues
eng
Pagination
80Subventions
Organisme : National Institute for Health and Care Research
ID : NIHR300582
Investigateurs
Avni Batish
(A)
Louisa Davidson
(L)
Sabrina Das
(S)
Lenka Magurova
(L)
George Haroun
(G)
Charlotte Meates
(C)
Gillian Houghton
(G)
Helen Le Grys
(HL)
Informations de copyright
© 2023. The Author(s).
Références
Arch Gynecol Obstet. 2014 Mar;289(3):523-31
pubmed: 23959092
Birth. 2021 Dec;48(4):558-565
pubmed: 34160107
Women Birth. 2018 Jun;31(3):e170-e177
pubmed: 28969997
Birth. 2018 Jun;45(2):202-209
pubmed: 29205469
Worldviews Evid Based Nurs. 2004;1(3):198-9
pubmed: 17163898
Midwifery. 2016 Mar;34:7-14
pubmed: 26971441
Lancet. 2014 May 31;383(9932):1863-4
pubmed: 24881976
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
BMC Pregnancy Childbirth. 2020 Jul 29;20(1):435
pubmed: 32727421
Eur J Midwifery. 2022 Jan 25;6:2
pubmed: 35118350
J Gynecol Obstet Hum Reprod. 2018 Feb;47(2):39-44
pubmed: 29208502
Midwifery. 2017 Dec;55:96-102
pubmed: 28987933
J Matern Fetal Neonatal Med. 2018 Nov;31(22):3002-3008
pubmed: 28760068
Cochrane Database Syst Rev. 2015 Apr 01;(4):CD000083
pubmed: 25828903
BMC Pregnancy Childbirth. 2016 Aug 26;16:248
pubmed: 27561416
Lancet. 2000 Oct 21;356(9239):1375-83
pubmed: 11052579
NIHR Open Res. 2022 Sep 16;2:45
pubmed: 36811097
Birth. 2022 Oct 26;:
pubmed: 36288483
Women Birth. 2013 Mar;26(1):e41-4
pubmed: 23062234
Midwifery. 2015 Jan;31(1):170-6
pubmed: 25168008
Patient Educ Couns. 2008 Aug;72(2):305-10
pubmed: 18534810
BJOG. 2005 Feb;112(2):218-22
pubmed: 15663587
BMC Pregnancy Childbirth. 2013 Jan 16;13:4
pubmed: 23324533
Midwifery. 2016 Dec;43:1-6
pubmed: 27788418
Pract Midwife. 2017 Feb;20(2):25-8
pubmed: 30462429
Int J Gynaecol Obstet. 2017 Feb;136(2):151-161
pubmed: 28099742
Birth. 2020 Jun;47(2):211-219
pubmed: 31960492
Z Geburtshilfe Neonatol. 2019 Jun;223(3):147-156
pubmed: 30536274
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:117-126
pubmed: 34182405
Trials. 2019 Apr 11;20(1):207
pubmed: 30971279
Midwifery. 2017 Jan;44:41-47
pubmed: 27889682